Sign in

CIK 0001746473

  • Non-accelerated filer
  • Smaller reporting company

PLIANT THERAPEUTICS, INC.

Sign in to watch
Ticker
PLRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474272481
Phone
+1 650-481-6770
Business address
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-03-30 Cummings Keith Lamont Chief Financial Officer Sale 10b5-1 −9,960 $26.52 $264K 148,470
2023-03-30 Coulie Bernard President and CEO Sale 10b5-1 −35,339 $26.52 $937K 274,753
2023-03-29 Ouimette Mike General Counsel & Corp. Sec'y Grant or award +13,593 58,540
2023-03-29 Lefebvre Eric Chief Medical Officer Grant or award +21,874 157,031
2023-03-29 Hull Hans Chief Business Officer Grant or award +17,578 211,000
2023-03-29 Cummings Keith Lamont Chief Financial Officer Grant or award +19,375 158,430
2023-03-29 Coulie Bernard President and CEO Grant or award +68,749 310,092
2023-03-06 MCCOURT Thomas A Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-03-06 Cline Darren S Director Grant or award · Stock Option (Right to Buy) +22,000 22,000
2023-02-03 Coulie Bernard President and CEO Exercise or conversion +15,000 $6.22 $93K 255,112
2023-02-03 Coulie Bernard President and CEO Sale −9,738 $33.36 $325K 245,374
2023-02-03 Coulie Bernard President and CEO Sale −5,262 $34.08 $179K 240,112
2023-02-03 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 327,262
2023-02-02 Coulie Bernard President and CEO Exercise or conversion +15,000 $6.22 $93K 255,112
2023-02-02 Coulie Bernard President and CEO Sale −13,395 $34.13 $457K 241,717
2023-02-02 Coulie Bernard President and CEO Sale −1,605 $34.96 $56K 240,112
2023-02-02 Coulie Bernard President and CEO Exercise or conversion · Stock Option (right to buy) −15,000 342,262
2023-02-01 Coulie Bernard President and CEO Exercise or conversion +15,000 $6.22 $93K 255,112
2023-02-01 Coulie Bernard President and CEO Sale −9,455 $34.15 $323K 245,657
2023-02-01 Coulie Bernard President and CEO Sale −5,440 $34.78 $189K 240,217

Page 9 of 19 · 379 trades